A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 278 participants.
Also called NCT01307033
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 278 participants
- Sponsor
- Registry
-
NCT01307033
-
- Other papers using this trial's data
- Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01307033. Randomized; double masking; primary purpose treatment. Start 2011-03-29 (actual); primary completion 2012-12-04 (actual). Results posted on 2014-01-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)
- Condition
- Hypertension
- Intervention (Drug)
- MK-0954A
- Intervention (Drug)
- MK-954H
- Intervention (Drug)
- Placebo to MK-0954A
- Intervention (Drug)
- Placebo to MK-954H
- Lead sponsor
- Organon and Co
Record details
- Record id
cardio:ct-nct01307033- Content hash
38139f08ca135876eb2ebfc7a9f3aa50d2e47b80d9d82a9586653069548da3c0